activin ligand-trap
Recombinant proteinexperimental
Clinical trial activity
1 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2025 (NCT07202000)
Timeline
2020s
- Jan 1, 2025
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Inhibin beta A chainANTAGONIST
INHBA antagonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07202000 | Phase 2 | Nov 1, 2025 | American Heart Association, Harvard University, Oakland University, University of Michigan |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| American Heart Association | Academic/Hospital | 1 | 0 | 1 | 2025 |
| Harvard University | Academic/Hospital | 1 | 1 | 1 | 2025 |
| Oakland University | Academic/Hospital | 1 | 0 | 1 | 2025 |
| University of Michigan | Academic/Hospital | 1 | 0 | 1 | 2025 |
4 organizations
Page 1 / 1